The Shiga-like toxins (Stx) are critical virulence factors for enterohemorrhagic Escherichia coli (EHEC), causing severe human illnesses of bloody diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome (HUS). A subunit of Stx, Stx1B protein, mediates the interaction between EHEC and the specific receptor of host organs. In this article, the recombinant expression vector pGEX-Stx1B bearing a signal peptide sequence-deleted Stx1B gene was constructed and the expression of protein of interest was achieved in a prokaryotic system. The resulting Stx1B protein was used to immunize BALB/c mice followed by the preparation of corresponding monoclonal antibodies (MAbs). One MAb (1G11) was generated. Western blot analysis showed that the MAb was capable of reacting with EHEC Stx1B protein. It had high affinity binding to the Stx1B protein and it distinguished EHEC from other control bacteria. Therefore, the MAb generated in this study can be used as a specific reagent to investigate the pathogenesis mechanism and to develop a diagnostic method of EHEC infection in both humans and animals.
Get full access to this article
View all access options for this article.
References
1.
GriffinPM, TauxeRV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev, 1991; 13:60–98.
2.
KarchH, BielaszewskaM, BitzanM, SchmidtH. Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. Diagn Microbiol Infect Dis, 1999; 34:229–243.
3.
ElliottEJ, Robins-BrowneRM, O'LoughlinEV, Bennett-WoodV, BourkeJ, HenningP, HoggGG, KnightJ, PowellH, RedmondD. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child, 2001; 85:125–131.
TeshVL, O'BrienAD. The pathogenic mechanisms of Shiga-toxin and the Shiga-like toxin. Mol Microbiol, 1991; 5:1817–1822.
9.
BastDJ, BruntonJL, KarmaliMA, RichardsonSE. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits. Infect Immun, 1997; 65:2019–2028.
10.
SteinPE, BoodhooA, TyrrellGJ, BruntonJL, ReadRJ. Crystal structure of the cell binding B oligomer of verotoxin-1 from Escherichia coli. Nature, 1992; 355:748–750.
11.
WolskiVM, SoltykAM, BruntonJL. Mouse toxicity and cytokine release by verotoxin 1B subunit mutants. Infect Immun, 2001; 69:579–583.
12.
EndoY, TsurgiK, YutsudoT, TakedaY, OgasawaraT, IgarashiK. Site of action of a vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. Eur J Biochem, 1988; 171:45–50.
13.
WadolkowskiEA, BurrisJA, O'BrienAD. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun, 1990; 58:2438–2445.
ZojaC, CornaD, FarinaC, SacchiG, LingwoodC, DoyleM, PadhyeVV, AbbateM, RemmuzziG. Tissue localization of verotoxin glycolipid receptor determines clinical expression of the disease in rabbits challenged with verotoxin-1. J Lab Clin Med, 1992; 120:229–238.
16.
SjogrenR, NeillR, RachmilewitzD, FritzD. Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic strains induced in rabbits. Gastroenterology, 1994; 106:306–317.
17.
LiuJ, SunY, FengS, ZhuL, GuoX, QiC. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins. Vaccine, 2009; 27:5929–5935.
18.
LiuB, LiG, SuiX, YinJ, WangH, RenX. Expression and functional analysis of porcine aminopeptidase N produced in prokaryotic expression system. J Biotechnol, 2009; 141:91–96.
19.
LiG, LillehojHS, MinW. Production and characterization of monoclonal antibodies reactive with the chicken interleukin-15 receptor alpha chain. Vet Immunol Immunopathol, 2001; 82:215–227.
20.
NewellDG, McBrideBW, ClarkSA. Making Monoclonals: A Practical Beginners Guide to the Production and Characterization of Monoclonal Antibodies Against Bacteria and Viruses. Public Health Laboratory Service: London, 1988.
21.
BeattyJD, BeattyBG, VlahosWG. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods, 1987; 100:173–179.
22.
RaghavaGP, AgrewalaJN. Method for determining the affinity of monoclonal antibody using non-competitive ELISA: a computer program. J Immunoassay, 1994; 15:115–128.
23.
CaprioliA, MorabitoS, BrugèreH, OswaldE. Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res, 2005; 36:289–311.
24.
LiG, ZengY, YinJ, LillehojHS, RenX. Cloning, prokaryotic expression, and biological analysis of recombinant chicken IFN-γHybridoma, 2010; 29:1–6.
25.
YinJ, LiG, RenX, HerrlerG. Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J Biotechnol, 2007; 127:335–347.
26.
HusseinHS, SakumaT. Prevalence of Shiga toxin-producing Escherichia coli in dairy cattle and their products. J Dairy Sci, 2005; 88:450–465.
27.
BesserTE, HancockDD, PritchettLC, McRaeEM, RiceDH, TarrPI. Duration of detection of fecal excretion of Escherichia coli O157:H7 in cattle. J Infect Dis, 1997; 175:726–729.
28.
Dean-NystromEA, BosworthBT, CrayWC, MoonHW. Pathogenecity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect Immun, 1997; 65:1842–1848.
29.
MechieSC, ChapmanPA, SiddonsCA. A fifteen-month study of Escherichia coli O157:H7 in a dairy herd. Epidemiol Infect, 1997; 118:17–25.
30.
SandhuKS, ClarkeRC, McFaddenK, BrouwerA, LouieM, WilsonJ, LiorH, GylesCL. Prevalence of the eaeA gene in verotoxigenic Escherichia coli strains from dairy cattle in Southwest Ontario. Epidemiol Infect, 1996; 116:1–7.
31.
ChiuehL, LiuF, ShihDY. Prevalence of Shiga toxin producing Escherichia coli in feed and raw milk of domestic cattle and sheep. J Food Drug Anal, 2002; 10:39–46.
32.
PradelN, BoukhorsK, BertinY, ForestierC, MartinC, LivrelliV. Heterogeneity of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients, cattle, and food samples in central France. Appl Environ Microbiol, 2001; 67:2460–2468.
33.
PradelN, LivrellV, de ChampsC, PalcouxJ, ReynaudA, ScheutzF, SirotJ, JolyB, ForestierC. Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. J Clin Microbiol, 2000; 38:1023–1031.
34.
DoyleMP. Escherichia coli O157:H7 and its significance in foods. Int J Food Microbiol, 1991; 12:289–302.
35.
StrockbineNA, MarquesLR, HolmesRK, O'BrienAD. Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect Immun, 1985; 50:695–700.
